000 04094nam a22003735i 4500
999 _c330933
_d330933
_x1
001 330933
003 ES-MaUEC
005 20230102114629.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 210226s2021 si | o |||| 0|eng d
020 _a9789813364042
024 7 _a10.1007/978-981-33-6404-2
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC360
_b2021 EB
245 0 0 _aMoyamoya Disease: Current Knowledge and Future Perspectives
_cedited by Satoshi Kuroda
250 _aPrimera edición
264 1 _aSingapore
_bSpringer International Publishing
_c2021
300 _a1 recurso en línea (XV, 341 páginas)
_b78 ilustraciones, 48 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aArchivo de texto
_bPDF
505 0 _aPart I Concept of Moyamoya Disease -- 1 History of Disease Entity & Diagnosis Criteria -- 2 Moyamoya Syndrome -- 3 Unilateral Moyamoya Disease: A Distinct Entity? -- Part II Genetic Aspect of Moyamoya Disease -- 4 RNF213 as Susceptibility Gene -- 5 RNF213 and clinical feature -- 6 RNF213 Variant as a Biomarker of Cerebrovascular Disease -- Part III Pathophysiology of Moyamoya Disease -- 7 TIA & Headache in Pediatric Moyamoya Disease -- 8 Ischemic stroke -- 9 Hemorrhagic Stroke and the Japan Adult Moyamoya Trial -- 10 Cognitive Function in Pediatric Moyamoya Disease -- 11 Cognitive Dysfunction in Adults -- 12 Asymptomatic Moyamoya Disease -- Part IV Update on Neuroradiology in Moyamoya Disease -- 13 Periventricular Anastomosis -- 14 Arterial Shrinkage -- 15 Disease progression -- 16 Postoperative hyperperfusion -- 17 Postoperative FLAIR Imaging Changes -- Part V Real World of Surgical Revascularization for Moyamoya Disease -- 18 Overview of Surgical Revascularization and Long-term Outcome in Japan -- 19 Perioperative complications -- 20 Long-term Outcome in Europe -- 21 Long Term Outcomes in USA -- 22 Long-term Outcome in China -- 23 Long-term outcome of revascularization surgery for moyamoya disease in Korea -- 24 Indirect bypass surgery for moyamoya disease -- 25 Direct/combined bypass surgery -- 26 Special Considerations-Infants -- 27 Special Considerations - Elderly.
520 3 _aThis book brings together the latest knowledge on moyamoya disease, covering diagnostic criteria, status as a disease entity, genetic aspects, pathophysiology, novel neuroradiological findings, and surgical therapy. Information is also provided on recent basic and clinical research with the aim of identifying future perspectives on the disease. Since moyamoya disease was first reported in an English language article more than 50 years ago, our understanding of it has advanced considerably. Genetic and radiological analysis has delivered novel insights, and the latest multicenter studies are changing routine diagnosis and surgical therapy. The gene encoding the ring finger protein 213 (RNF213) has been identified as a susceptibility gene for moyamoya disease. Indications and procedures for surgical revascularization have been revised, with resultant improvements in outcomes, and studies performed over the past decade have provided new knowledge on the neuroradiological findings before and after surgery. In describing these advances, this book will be an invaluable asset for all general physicians, pediatricians, neurologists, radiologists, and neurosurgeons who care for patients with moyamoya disease across the world.
988 _aSpringer_Medicine_2021
650 7 _2embne
_aSistema nervioso central
_xEnfermedades
_9188115
700 1 _aKuroda, Satoshi
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-33-6404-2
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
_n0
998 _b03/2021
_dz
_eu
_zSI